INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹14 Cr | ₹-2.75 Cr | ₹3.31 Cr | ₹-6.54 Cr | ₹8.05 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDOCO REMEDIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹14 Cr |
| Mar2025 | ₹-2.75 Cr |
| Mar2024 | ₹3.31 Cr |
| Mar2023 | ₹-6.54 Cr |
| Mar2022 | ₹8.05 Cr |
How is Net Cash Inflow / Outflow of INDOCO REMEDIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹14 Cr | Positive | |
| Mar2025 | ₹-2.75 Cr | Negative | |
| Mar2024 | ₹3.31 Cr | Positive | |
| Mar2023 | ₹-6.54 Cr | Negative | |
| Mar2022 | ₹8.05 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,994.6 Cr | 0.1% | -12.3% | -22.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 0.1% |
-12.3% |
-22.8% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses